Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastasesPUBT·10 hours ago
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectivesPUBT·1 day ago, 07:55 AMCNXU-12.91%
ChronicleBio Cofounder Fidji Simo Says AI Could Transform Disease Treatment, But Smarter Models Aren’t Enoughbenzinga_article·1 day ago, 04:40 AM
IDXX: Innovation and sector tailwinds support double-digit recurring revenue growth and expanding marginsQuartr·Aug 13 at 01:50 PMIDXX+2.43%
BlackRock Health Sciences Term Trust files Form 3 for Chief Compliance Officer Charles ParkPUBT·Aug 5 at 06:12 PMBMEZ+4.67%
The Interest Rate "Surprise" Everyone's Ignoring (and the 10.3% Dividend That Profits From it)nasdaq·May 19 at 08:35 AMBMEZ+4.67%DSL+0.80%
BlackRock announced updates to the managed dividend plans for BMEZ, BSTZ, and BTXZhitong·Sep 10, 2025 at 07:06 PMBMEZ+4.67%
BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer | BMEZ Stock NewsStockTitan·Apr 21, 2025 at 07:53 PMBMEZ+4.67%
BlackRock Health Sciences Term Trust (BMEZ) Announces Expiration and Preliminary Results of Tender Offer | BMEZ Stock NewsStockTitan·Apr 17, 2025 at 08:31 PMBMEZ+4.67%
